Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Date Time Source Announcement
01 Oct 2021 9:51 am
RNS
Total Voting Rights
29 Sep 2021 5:54 pm
RNS
Holding(s) in Company
  5:36 pm
RNS
Directors Dealings / Market Share Purchases
28 Sep 2021 4:48 pm
RNS
Holding(s) in Company
  10:01 am
RNS
Total Voting Rights
22 Sep 2021 7:38 am
RNS
Strategic investment by Serum Life Sciences
  7:00 am
RNS
Interim Results
01 Sep 2021 10:48 am
RNS
Total Voting Rights
  7:00 am
RNS
Notice of Interim Results
03 Aug 2021 2:20 pm
RNS
LTIP Option Grant
02 Aug 2021 11:16 am
RNS
Total Voting Rights
15 Jul 2021 7:00 am
RNS
Non-Executive Director Appointment
06 Jul 2021 3:10 pm
RNS
Director/PDMR Shareholding
01 Jul 2021 11:35 am
RNS
Block listing Return
  10:43 am
RNS
Total Voting Rights
24 Jun 2021 1:05 pm
RNS
Directors Dealings / Market Share Purchases
09 Jun 2021 10:36 am
RNS
Holding(s) in Company
08 Jun 2021 2:32 pm
RNS
Grant of options
01 Jun 2021 10:13 am
RNS
Total Voting Rights
28 May 2021 7:00 am
EQS
Oxford Biomedica (OXB): Driving innovation in a thriving CGT industry
  7:00 am
RNS
Block Listing Application
  7:00 am
RNS
Result of AGM
27 May 2021 7:00 am
RNS
Board Change
25 May 2021 9:21 am
RNS
Director/PDMR Shareholding
21 May 2021 12:46 pm
RNS
PDMR Dealing
20 May 2021 11:42 am
RNS
PDMR Dealings
18 May 2021 7:00 am
RNS
Oxford Biomedica upgrades financial guidance
  7:00 am
GNW
Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 Vaccine
10 May 2021 10:54 am
RNS
Holding(s) in Company
04 May 2021 10:29 am
RNS
Total Voting Rights
  10:27 am
RNS
Holdings in Company
27 Apr 2021 2:40 pm
RNS
2020 Annual report and Accounts & AGM Notification
26 Apr 2021 12:32 pm
RNS
Holding(s) in Company
15 Apr 2021 7:00 am
RNS
Full year results
06 Apr 2021 7:00 am
RNS
OXB signs Agreement with Boehringer Ingelheim
01 Apr 2021 11:04 am
RNS
Total Voting Rights
30 Mar 2021 10:22 am
RNS
Holding(s) in Company
19 Mar 2021 7:01 am
RNS
Update on Sanofi Collaboration & License Agreement
15 Mar 2021 10:03 am
RNS
Notice of Preliminary Results
01 Mar 2021 9:36 am
RNS
Total Voting Rights
26 Feb 2021 10:46 am
RNS
PDMR Dealings / Market Share sale
05 Feb 2021 1:22 pm
RNS
Holdings in Company
03 Feb 2021 7:00 am
RNS
Board Changes
01 Feb 2021 9:47 am
RNS
Total Voting Rights
18 Jan 2021 4:34 pm
RNS
Prime Minister Boris Johnson formally opens Oxbox
04 Jan 2021 2:09 pm
RNS
Block Listing Return
  1:41 pm
RNS
Total Voting Rights
30 Dec 2020 9:03 am
RNS
OXB notes AZ vaccine has been authorised in the UK
01 Dec 2020 12:17 pm
RNS
Director Dealings
  9:02 am
RNS
Total Voting Rights
23 Nov 2020 8:47 am
RNS
OXB notes AZD1222 met primary efficacy endpoint
  7:00 am
RNS
Non-Executive Director Appointment
09 Nov 2020 7:00 am
RNS
OXB and PhoreMost enter gene therapy collaboration
02 Nov 2020 9:02 am
RNS
Total Voting Rights
30 Oct 2020 7:00 am
RNS
Axovant update on AXO-Lenti-PD and virtual R&D day
23 Oct 2020 10:27 am
RNS
Director Purchase
12 Oct 2020 5:38 pm
RNS
Holding(s) in Company
06 Oct 2020 12:46 pm
RNS
Axovant update on 2nd cohort of SUNRISE-PD trial
  7:00 am
RNS
OXB receives approval for fourth suite in Oxbox
05 Oct 2020 10:59 am
EQS
Oxford Biomedica (OXB): Vector innovation key to cell and gene evolution
02 Oct 2020 11:52 am
RNS
Total Voting Rights
29 Sep 2020 3:51 pm
RNS
Director Dealings
24 Sep 2020 9:36 am
RNS
Director/PDMR Shareholding
22 Sep 2020 12:54 pm
RNS
Director/PDMR Shareholding
17 Sep 2020 7:00 am
RNS
Interim Results
01 Sep 2020 9:33 am
RNS
Total Voting Rights
  7:00 am
RNS
Master Supply and Development Agreement with AZ
27 Aug 2020 7:00 am
RNS
Notice of Interim Results
25 Aug 2020 4:46 pm
RNS
Block listing Application
03 Aug 2020 9:41 am
RNS
Total Voting Rights
  7:00 am
RNS
OXB signs DMLA with Beam Therapeutics
31 Jul 2020 7:00 am
RNS
OXB Signs Clinical Supply Agreement with Axovant
20 Jul 2020 4:23 pm
RNS
OXB notes interim results from AZ on AZD1222
03 Jul 2020 10:45 am
RNS
Director Dealings / Market Share Purchase
02 Jul 2020 3:39 pm
RNS
Director Dealings / Market Share Purchase
  1:34 pm
RNS
Director Dealings / Market Share Transactions
01 Jul 2020 6:30 pm
RNS
Holdings in Company
  3:44 pm
RNS
Block listing Return
  9:13 am
RNS
Total Voting Rights
30 Jun 2020 3:23 pm
RNS
Grant of options
25 Jun 2020 9:44 am
RNS
Holding(s) in Company
24 Jun 2020 11:45 am
RNS
Holdings in Company
  9:54 am
RNS
Director Dealings / Share Disposal - Replacement
23 Jun 2020 4:46 pm
RNS
Result of Annual General Meeting
  2:47 pm
RNS
Admission of shares and Total Voting Rights.
  7:00 am
RNS
Annual General Meeting
19 Jun 2020 3:26 pm
RNS
Information in Relation to Annual General Meeting
  7:00 am
RNS
Result of Placing
18 Jun 2020 5:33 pm
RNS
Proposed Placing of new Ordinary Shares
08 Jun 2020 4:01 pm
RNS
Update on Sanofi Ophthalmology Programmes
  7:00 am
RNS
Five Year Collaboration Agreement signed with VMIC
01 Jun 2020 9:06 am
RNS
Total Voting Rights
  7:00 am
RNS
Dr Roch Doliveux appointed Non-Executive Chairman
28 May 2020 12:16 pm
RNS
Clinical & Commercial Supply Agreement with AZ
27 May 2020 11:26 am
RNS
Director Dealings / Market Share Purchase
22 May 2020 5:28 pm
RNS
2019 Annual report and Accounts & AGM Notification
20 May 2020 2:34 pm
RNS
Holding(s) in Company
13 May 2020 6:02 pm
RNS
Holding(s) in Company
  7:00 am
RNS
OXB receives approval for first two Oxbox suites
11 May 2020 4:25 pm
RNS
PDMR Dealings / Market Share sale
06 May 2020 12:36 pm
RNS
Directors Dealings / Market Share Purchases
  7:00 am
RNS
Preliminary Results
01 May 2020 9:05 am
RNS
Total Voting Rights
28 Apr 2020 1:04 pm
RNS
Compliance with LR 9.2.6ER(1)
24 Apr 2020 11:48 am
RNS
Director/PDMR Shareholding
23 Apr 2020 8:38 am
RNS
Holding(s) in Company
22 Apr 2020 12:03 pm
RNS
Kymriah receives FDA RMAT designation in FL
20 Apr 2020 4:49 pm
RNS
Holding(s) in Company
16 Apr 2020 3:17 pm
RNS
Notice of Results Update
08 Apr 2020 7:00 am
RNS
Oxford Biomedica joins COVID-19 vaccine Consortium
01 Apr 2020 9:31 am
RNS
Total Voting Rights
25 Mar 2020 1:06 pm
RNS
Director Dealings / Market Share Purchase
20 Mar 2020 9:56 am
RNS
Director/PDMR Shareholding
18 Mar 2020 7:00 am
RNS
Oxford Biomedica Business Update
  7:00 am
RNS
License & Supply Agreement with Juno Therapeutics
02 Mar 2020 9:22 am
RNS
Total Voting Rights
26 Feb 2020 5:55 pm
RNS
Director Dealings / Market Share Purchase
03 Feb 2020 5:04 pm
RNS
Class 2 Transaction Announcement
  11:56 am
RNS
Total Voting Rights
  11:55 am
RNS
Director Dealings / Market Share Purchase
22 Jan 2020 12:11 pm
RNS
Block listing Application
07 Jan 2020 10:17 am
RNS
Block Listing Return
02 Jan 2020 11:41 am
RNS
Total Voting Rights
19 Dec 2019 3:27 pm
RNS
Director Dealings / Market Share Purchase
  7:00 am
RNS
Extension of Commercial Supply Agreement
02 Dec 2019 9:31 am
RNS
Total Voting Rights
27 Nov 2019 10:05 am
RNS
Director Dealings / Market Share Purchase
13 Nov 2019 4:41 pm
RNS
Holding(s) in Company
01 Nov 2019 9:25 am
RNS
Total Voting Rights
28 Oct 2019 12:30 pm
RNS
Director Dealings / Market Share Purchase
23 Oct 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
16 Oct 2019 7:30 am
EQS
Oxford BioMedica (OXB): Demanding second half
01 Oct 2019 10:18 am
RNS
Total Voting Rights
25 Sep 2019 11:41 am
RNS
Director Dealings / Market Share Purchase
16 Sep 2019 11:18 am
RNS
Director/PDMR Shareholding
  9:15 am
RNS
Directors Dealings / Market Share Purchases
13 Sep 2019 2:57 pm
RNS
Long Term Incentive Plan Option Grant
  1:13 pm
RNS
Directors Dealings / Market Share Purchases
  10:53 am
RNS
Director Dealings / Market Share Purchase
04 Sep 2019 7:00 am
RNS
Oxford Biomedica Interim Results
02 Sep 2019 9:31 am
RNS
Total Voting Rights
23 Aug 2019 11:06 am
RNS
Director Dealings / Market Share Purchase
09 Aug 2019 12:00 pm
RNS
Notice of Interim Results
01 Aug 2019 9:18 am
RNS
Total Voting Rights
25 Jul 2019 2:17 pm
RNS
Director Dealings / Market Share Purchase
01 Jul 2019 11:03 am
EQS
Oxford BioMedica (OXB): Eying up long-term value
  10:01 am
RNS
Block listing Interim Review
  9:32 am
RNS
Total Voting Rights
28 Jun 2019 7:00 am
RNS
Repayment of Debt Facility
26 Jun 2019 2:52 pm
RNS
Director Dealings / Market Share Purchase
  7:00 am
RNS
OXB and Santen enter R&D collaboration
25 Jun 2019 7:00 am
RNS
Board Change
18 Jun 2019 7:15 am
EQS
Oxford BioMedica (OXB): De-leveraging the balance sheet
10 Jun 2019 2:34 pm
RNS
Director/PDMR Shareholding
06 Jun 2019 1:08 pm
RNS
Axovant update on 1st cohort of Sunrise-PD trial
  11:39 am
RNS
Holding(s) in Company
05 Jun 2019 12:06 pm
RNS
Holdings in Company
04 Jun 2019 5:38 pm
RNS
Holdings in Company
  9:59 am
RNS
Total Voting Rights
03 Jun 2019 6:06 pm
RNS
Holding(s) in Company
  10:31 am
RNS
Total Voting Rights
29 May 2019 6:19 pm
RNS
Exercise of Subscription Option by Novo Holdings
  1:06 pm
RNS
Result of AGM
28 May 2019 7:00 am
RNS
Strategic Investment by Novo Holdings A/S
23 May 2019 6:04 pm
RNS
Director Dealings / Market Share Purchase
02 May 2019 2:53 pm
RNS
Long Term Incentive Plan Option Grant
01 May 2019 12:52 pm
RNS
REPLACEMENT: Total Voting Rights
30 Apr 2019 5:38 pm
RNS
Holdings in Company
  1:35 pm
RNS
Oxford Biomedica to present at the ASGCT
  1:15 pm
RNS
Axovant doses second cohort of AXO-Lenti-PD
25 Apr 2019 3:38 pm
RNS
Director Dealings / Market Share Purchase
23 Apr 2019 1:47 pm
RNS
Deferred Bonus Plan and LTIP Option Grants
  11:38 am
RNS
Director Dealings / Market Share Transactions
18 Apr 2019 5:33 pm
RNS
Exercise of warrants
  7:00 am
RNS
Annual Report and Accounts & AGM Notification
02 Apr 2019 7:15 am
EQS
Oxford BioMedica (OXB): Deal-making drives first annual profit
01 Apr 2019 11:40 am
RNS
Total Voting Rights
26 Mar 2019 12:57 pm
RNS
Director Dealings / Market Share Purchase
  8:25 am
RNS
Japanese approval of Kymriah? (tisagenlecleucel)
14 Mar 2019 7:00 am
RNS
Preliminary Results
12 Mar 2019 7:00 am
RNS
OXB announces R&D collaboration with Microsoft
11 Mar 2019 10:38 am
RNS
Axovant's update on Phase 2 trial of AXO-Lenti-PD
01 Mar 2019 9:30 am
RNS
Total Voting Rights
25 Feb 2019 12:23 pm
RNS
Director Dealings / Market Share Purchase
08 Feb 2019 7:00 am
RNS
Notice of Results
07 Feb 2019 11:49 am
RNS
Director/PDMR Shareholding
  9:22 am
RNS
Update on programmes outlicensed to Sanofi
06 Feb 2019 11:00 am
RNS
Director Dealings / Market Share Transactions
05 Feb 2019 10:22 am
RNS
Director Dealings / Market Share Purchase
01 Feb 2019 10:00 am
RNS
Total Voting Rights
24 Jan 2019 11:20 am
RNS
Director Dealings / Market Share Purchase
18 Jan 2019 10:51 am
RNS
Director Dealings / Market Share Purchase
03 Jan 2019 12:20 pm
RNS
Block listing Interim Review
02 Jan 2019 10:17 am
RNS
Total Voting Rights
21 Dec 2018 1:16 pm
RNS
Director Dealings / Market Share Purchase
06 Dec 2018 4:11 pm
RNS
Axovant FDA meeting feedback
03 Dec 2018 9:53 am
RNS
Total Voting Rights
  7:00 am
RNS
Longer term Kymriah efficacy and safety data
23 Nov 2018 10:41 am
RNS
Director Dealings
  7:00 am
RNS
Oxford Biomedica form digital framework initiative
09 Nov 2018 7:00 am
RNS
Block listing application
01 Nov 2018 2:41 pm
RNS
Total Voting Rights
25 Oct 2018 7:00 am
RNS
Axovant Doses First Patient with AXO-Lenti-PD
22 Oct 2018 4:39 pm
RNS
Director Dealings / Market Share Purchase
05 Oct 2018 7:00 am
RNS
Details of alliance with Orchard Therapeutics
01 Oct 2018 9:41 am
RNS
Total Voting Rights
24 Sep 2018 12:20 pm
RNS
Director/PDMR Shareholding
20 Sep 2018 10:55 am
EQS
Oxford BioMedica (OXB): Partnering strategy delivering profitability
13 Sep 2018 7:00 am
RNS
Oxford BioMedica Interim Results
  7:00 am
RNS
Oxford BioMedica further capacity expansion
03 Sep 2018 9:18 am
RNS
Total Voting Rights
28 Aug 2018 7:00 am
RNS
Kymriah? receives European Commission Approval
22 Aug 2018 11:58 am
RNS
Director/PDMR Shareholding
15 Aug 2018 7:00 am
RNS
RNS notice of results OXB
14 Aug 2018 7:15 am
EQS
Oxford BioMedica (OXB): Risk-sharing in cystic fibrosis gene-therapy
13 Aug 2018 10:55 am
RNS
Director/PDMR Shareholding
  10:48 am
RNS
Director/PDMR Shareholding
10 Aug 2018 11:39 am
RNS
PDMR Dealings / Market Share Sale
  11:36 am
RNS
Director Dealings / Market Share Sale and Purchase
08 Aug 2018 2:45 pm
RNS
Share Options and LTIPs Granted
06 Aug 2018 7:02 am
RNS
Partnership for Cystic Fibrosis Gene Therapy
01 Aug 2018 9:53 am
RNS
Total Voting Rights
23 Jul 2018 12:54 pm
RNS
Director Dealings / Market Share Purchase
02 Jul 2018 10:25 am
RNS
Directorate Change
  9:47 am
RNS
Total Voting Rights
29 Jun 2018 1:37 pm
RNS
Kymriah receives positive CHMP opinion
25 Jun 2018 5:19 pm
RNS
Holdings in Company
22 Jun 2018 12:05 pm
RNS
Confirmation of change of Auditor
  12:03 pm
RNS
Director Dealings / Market Share Purchase
21 Jun 2018 5:52 pm
RNS
Holdings in Company
14 Jun 2018 9:50 am
EQS
Oxford BioMedica (OXB): Gene-therapy for Parkinson's: clinical progression
06 Jun 2018 7:00 am
RNS
OXB and Axovant Sciences Licence Agreement
04 Jun 2018 6:08 pm
RNS
Directorate Change
01 Jun 2018 9:24 am
RNS
Block Listing Return
  9:19 am
RNS
Total Voting Rights
30 May 2018 4:23 pm
RNS
Holdings in Company
29 May 2018 1:21 pm
RNS
Result of General Meeting
  1:21 pm
RNS
Result of AGM
23 May 2018 1:40 pm
RNS
Director Dealings / Market Share Purchase
04 May 2018 7:00 am
RNS
Proposed Share Capital Consolidation
02 May 2018 7:00 am
RNS
Kymriah receives FDA approval for DLBCL
01 May 2018 9:37 am
RNS
Total Voting Rights
26 Apr 2018 3:33 pm
RNS
Holding(s) in Company
  7:30 am
RNS
2017 Annual Report and Accounts & AGM Notification
23 Apr 2018 11:46 am
RNS
Director Dealings / Market Share Purchase
11 Apr 2018 2:11 pm
RNS
Director Dealings / Market Share Purchase
09 Apr 2018 5:39 pm
RNS
Director/PDMR Shareholding
  10:47 am
RNS
Director/PDMR Shareholding
05 Apr 2018 12:08 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 9:45 am
RNS
Total Voting Rights
22 Mar 2018 11:05 am
RNS
Director/PDMR Shareholding
20 Mar 2018 7:15 am
RNS
Hardman & Co Res: Supply to meet demand
15 Mar 2018 7:01 am
RNS
Board Change
  7:01 am
RNS
Preliminary Results
09 Mar 2018 6:41 pm
RNS
Result of Placing
  3:42 pm
RNS
PROPOSED PLACING TO RAISE APPROXIMATELY �20.5M
01 Mar 2018 9:33 am
RNS
Total Voting Rights
28 Feb 2018 7:15 am
RNS
Hardman & Co Res: BIVV deal establishes structure
23 Feb 2018 2:03 pm
RNS
Director/PDMR Shareholding
20 Feb 2018 2:12 pm
RNS
Holdings in Company
15 Feb 2018 7:00 am
RNS
Bioverativ Collaboration and Licence Agreement
01 Feb 2018 11:28 am
RNS
Total Voting Rights
23 Jan 2018 9:45 am
RNS
�3 million Innovate UK grant
  9:30 am
RNS
Director Dealings / Market Share Purchase
17 Jan 2018 7:00 am
RNS
Kymriah receives Priority Review for adult DLBCL
09 Jan 2018 9:54 am
RNS
BLOCK LISTING RETURN
03 Jan 2018 1:33 pm
RNS
Holding(s) in Company
02 Jan 2018 9:49 am
RNS
Total Voting Rights
20 Dec 2017 11:22 am
RNS
Director Dealings / Market Share Purchase
11 Dec 2017 7:08 am
RNS
Primary analysis results from JULIET trial
01 Dec 2017 10:16 am
RNS
Total Voting Rights
23 Nov 2017 11:29 am
RNS
Director Dealings / Market Share Purchase
09 Nov 2017 7:00 am
RNS
OXB to present at Jefferies Healthcare Conference
06 Nov 2017 12:06 pm
RNS
Holdings in Company
  7:37 am
RNS
CTL019 MAA submission to the EMA
01 Nov 2017 9:19 am
RNS
Total Voting Rights
31 Oct 2017 4:01 pm
RNS
Kymriah submitted to FDA for adults with r/r DLBCL
23 Oct 2017 11:27 am
RNS
Director Dealings / Market Share Purchase
02 Oct 2017 11:21 am
RNS
Total Voting Rights
26 Sep 2017 2:55 pm
RNS
Director Dealings / Market Share Purchase
  9:37 am
RNS
Long Term Incentive Plan Option Grant
25 Sep 2017 3:05 pm
RNS
Block listing application
  9:46 am
RNS
Cantor Fitzgerald Healthcare Conference 2017
22 Sep 2017 12:36 pm
RNS
Director Dealings
20 Sep 2017 3:25 pm
RNS
Holding(s) in Company
19 Sep 2017 8:58 am
RNS
Director Dealings
15 Sep 2017 9:21 am
RNS
Director/PDMR Shareholding
12 Sep 2017 7:15 am
RNS
Hardman Research: New advanced therapies era
07 Sep 2017 10:11 am
RNS
Holdings in Company
05 Sep 2017 11:45 am
RNS
Director/PDMR Shareholding
  11:39 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
OXB to Present at Rodman & Renshaw Conference
01 Sep 2017 9:25 am
RNS
Total Voting Rights
30 Aug 2017 4:34 pm
RNS
CTL019 receives FDA approval
29 Aug 2017 7:00 am
RNS
Stuart Paynter starts as new CFO
24 Aug 2017 10:41 am
RNS
Hardman Research: Ready for CTL019 approval
23 Aug 2017 10:31 am
RNS
Director Dealings / Market Share Purchase
22 Aug 2017 10:35 am
RNS
Director Dealings / Market Share Sale and Purchase
17 Aug 2017 7:00 am
RNS
Interim Results
11 Aug 2017 7:00 am
RNS
OXB announces Innovate UK �2m collaboration
07 Aug 2017 9:05 am
RNS
Holding(s) in Company
  7:00 am
RNS
MHRA Licence For Commercial Supply
01 Aug 2017 9:19 am
RNS
Total Voting Rights
25 Jul 2017 7:00 am
RNS
Notice of Interim Results
24 Jul 2017 10:10 am
RNS
Director Dealings / Market Share Purchase
18 Jul 2017 8:47 am
RNS
Director Dealings / Market Share Sale and Purchase
17 Jul 2017 12:31 pm
RNS
Director Dealings
14 Jul 2017 4:49 pm
RNS
Director/PDMR Shareholding
  3:30 pm
RNS
PDMR Shareholding
  11:41 am
RNS
LTIP for Long Term Incentive Plan
13 Jul 2017 12:38 pm
RNS
Director Dealings / Market Share Sale and Purchase
  7:15 am
RNS
Holdings in Company
  7:00 am
RNS
FDA AdCom Recommends CTL019 for Approval
11 Jul 2017 9:29 am
RNS
Director Dealings / Market Share Sale and Purchase
07 Jul 2017 10:15 am
RNS
Hardman Research: Major deal to supply Novartis
06 Jul 2017 7:15 am
RNS
Holding(s) in Company
  7:00 am
RNS
Major Commercial and Clinical Supply Agreement
03 Jul 2017 2:20 pm
RNS
Total Voting Rights
  2:18 pm
RNS
Block Listing
30 Jun 2017 10:38 am
RNS
Refinancing of Debt Facility
23 Jun 2017 10:12 am
RNS
Director Dealings / Market Share Purchase
14 Jun 2017 3:00 pm
RNS
Findings from Phase II JULIET Study
07 Jun 2017 7:00 am
RNS
OXB notes FDA Advisory Committee to review CTL019
02 Jun 2017 7:00 am
RNS
OXB to Present at Jefferies Healthcare Conference
01 Jun 2017 12:22 pm
RNS
Total Voting Rights
24 May 2017 1:55 pm
RNS
Director/PDMR Shareholding
23 May 2017 2:03 pm
RNS
Result of AGM
04 May 2017 8:46 am
RNS
Total Voting Rights
28 Apr 2017 7:00 am
RNS
Annual Report and Accounts & AGM Notification
24 Apr 2017 10:17 am
RNS
Director/PDMR Shareholding
04 Apr 2017 7:00 am
RNS
Holding(s) in Company
03 Apr 2017 9:11 am
RNS
Total Voting Rights
31 Mar 2017 7:15 am
RNS
Hardman: Delivering commercial gene-therapy vector
30 Mar 2017 7:02 am
RNS
BLA filing for CTL019
27 Mar 2017 10:44 am
RNS
Publication in the Journal Nature Communications
23 Mar 2017 1:47 pm
RNS
Director Dealings
22 Mar 2017 7:00 am
RNS
Holding(s) in Company
16 Mar 2017 7:00 am
RNS
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2016
10 Mar 2017 7:00 am
RNS
Notice of Preliminary Results
01 Mar 2017 10:24 am
RNS
Total Voting Rights
28 Feb 2017 7:00 am
RNS
Appointment of New Chief Financial Officer
24 Feb 2017 9:36 am
RNS
Director Dealings
  7:00 am
RNS
Results of TroVax? in Advanced Colorectal Cancer
01 Feb 2017 10:09 am
RNS
Total Voting Rights
25 Jan 2017 9:02 am
RNS
Director/PDMR Shareholding
24 Jan 2017 4:34 pm
RNS
Director Dealings / Market Share Purchase
  9:31 am
RNS
Director/PDMR Shareholding
23 Jan 2017 9:57 am
RNS
Director/PDMR Shareholding
03 Jan 2017 9:30 am
RNS
Block Listing Return
  9:28 am
RNS
Total Voting Rights
20 Dec 2016 8:57 am
RNS
Director/PDMR Shareholding
12 Dec 2016 10:52 am
RNS
Block listing application
06 Dec 2016 9:15 am
RNS
Director/PDMR Shareholding
05 Dec 2016 10:25 am
RNS
Findings Reported by Novartis on CTL-019 at ASH
  9:43 am
RNS
Director/PDMR Shareholding
01 Dec 2016 9:27 am
RNS
Total Voting Rights
29 Nov 2016 7:00 am
RNS
Strategic Alliance with Orchard Therapeutics
28 Nov 2016 10:06 am
RNS
Director/PDMR Shareholding
08 Nov 2016 6:28 pm
RNS
Grant of options (Replacement)
01 Nov 2016 10:21 am
RNS
Total Voting Rights
25 Oct 2016 4:40 pm
RNS
Director/PDMR Shareholding
10 Oct 2016 7:21 am
RNS
Publication of RetinoStat? (OXB-201) Phase I study
06 Oct 2016 9:24 am
RNS
Holding(s) in Company
05 Oct 2016 10:17 am
RNS
Holding(s) in Company
04 Oct 2016 11:57 am
RNS
Holding(s) in Company
  8:16 am
RNS
Admission to Trading and Total Voting Rights
29 Sep 2016 12:27 pm
RNS
Result of General Meeting and Directors Dealing
26 Sep 2016 11:00 am
RNS
Director/PDMR Shareholding
13 Sep 2016 3:07 pm
RNS
Publication of Prospectus
  7:01 am
RNS
FUNDRAISING OF �10 MILLION
  7:00 am
RNS
INTERIM RESULTS FOR 6 MONTHS ENDED 30 JUNE 2016
01 Sep 2016 10:47 am
RNS
Total Voting Rights
25 Aug 2016 2:22 pm
RNS
Director/PDMR Shareholding
02 Aug 2016 4:35 pm
RNS
Price Monitoring Extension
  9:32 am
RNS
Total Voting Rights
28 Jul 2016 7:00 am
RNS
Manufacturing Approvals and Expansion Completed
25 Jul 2016 9:56 am
RNS
Director/PDMR Shareholding
08 Jul 2016 12:02 pm
RNS
Price Monitoring Extension
04 Jul 2016 9:14 am
RNS
Block Listing Return
  9:12 am
RNS
Total Voting Rights
28 Jun 2016 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Second Price Monitoring Extn
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
27 Jun 2016 10:37 am
RNS
Director/PDMR Shareholding
22 Jun 2016 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
16 Jun 2016 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
15 Jun 2016 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
07 Jun 2016 1:14 pm
RNS
Oxford BioMedica Annual General Meeting
  7:00 am
RNS
New Non-Exclusive LentiVector Licence with MolMed
06 Jun 2016 3:29 pm
RNS
OXB to Present at Jefferies Healthcare Conference
02 Jun 2016 10:05 am
RNS
R&D Partnership with Green Cross LabCell
  9:30 am
RNS
Total Voting Rights
24 May 2016 10:08 am
RNS
Director/PDMR Shareholding
18 May 2016 7:00 am
RNS
Deferred Bonus Plan and LTIP Option Grants
17 May 2016 7:00 am
RNS
Oxford BioMedica Appoints Corporate Broker
16 May 2016 9:23 am
RNS
Director/PDMR Shareholding
  9:16 am
RNS
Director/PDMR Shareholding
12 May 2016 7:00 am
RNS
Oxford BioMedica Board Change
06 May 2016 12:21 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Long-Term Expression of LentiVector
05 May 2016 5:50 pm
RNS
2015 Annual Report and Accounts & AGM Notification
  9:22 am
RNS
Director/PDMR Shareholding
04 May 2016 8:48 am
RNS
Director/PDMR Shareholding
03 May 2016 12:57 pm
RNS
Director/PDMR Shareholding
  9:25 am
RNS
Total Voting Rights
29 Apr 2016 1:35 pm
RNS
Director Shareholding
28 Apr 2016 7:00 am
RNS
Preliminary Results for the Year Ended 31 Dec 2015
26 Apr 2016 7:00 am
RNS
Stuart Henderson Appointed as a NED
25 Apr 2016 8:48 am
RNS
Director/PDMR Shareholding
15 Apr 2016 8:50 am
RNS
Holding(s) in Company
01 Apr 2016 9:01 am
RNS
Total Voting Rights
24 Mar 2016 9:27 am
RNS
Director Dealings
11 Mar 2016 4:28 pm
RNS
Holding(s) in Company
07 Mar 2016 7:00 am
RNS
Immune Design Collaboration and Licence Expanded
01 Mar 2016 11:04 am
RNS
Total Voting Rights
  9:46 am
RNS
Holding(s) in Company
  9:44 am
RNS
Holding(s) in Company
  9:38 am
RNS
Notice of Preliminary Results date: 28 April 2016
29 Feb 2016 12:16 pm
RNS
Director/PDMR Shareholding
26 Feb 2016 4:42 pm
RNS
Holding(s) in Company
25 Feb 2016 5:16 pm
RNS
Director/PDMR Shareholding
  2:46 pm
RNS
Holding(s) in Company
  2:45 pm
RNS
Director/PDMR Shareholding
  9:36 am
RNS
Holding(s) in Company
23 Feb 2016 7:00 am
RNS
Placing to raise �8.1 Million
16 Feb 2016 10:59 am
RNS
Holding(s) in Company
11 Feb 2016 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
02 Feb 2016 9:37 am
RNS
Total Voting Rights
29 Jan 2016 7:00 am
RNS
Initiation of Second CART Programme for Novartis
13 Jan 2016 7:00 am
RNS
MHRA approval to manufacture in new facility
05 Jan 2016 7:00 am
RNS
Directorate Change
04 Jan 2016 7:00 am
RNS
Blocklisting Interim Review
  7:00 am
RNS
Total Voting Rights
21 Dec 2015 2:11 pm
RNS
Total Voting Rights
15 Dec 2015 7:00 am
RNS
Appointment of New Chairman
02 Dec 2015 11:14 am
RNS
Total Voting Rights
30 Nov 2015 11:32 am
RNS
Holding(s) in Company
20 Nov 2015 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
18 Nov 2015 9:43 am
RNS
OXB present at Jefferies Healthcare Conference
13 Nov 2015 4:35 pm
RNS
Price Monitoring Extension
04 Nov 2015 7:00 am
RNS
Business Update
02 Nov 2015 7:00 am
RNS
Total Voting Rights
28 Oct 2015 7:00 am
RNS
GSK Exercises Option on OXB LentiVector Patents
01 Oct 2015 4:10 pm
RNS
Total Voting Rights
11 Sep 2015 4:35 pm
RNS
Price Monitoring Extension
01 Sep 2015 7:03 am
RNS
Total Voting Rights
27 Aug 2015 7:00 am
RNS
Interim Results
06 Aug 2015 5:16 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of Interim Results
03 Aug 2015 7:00 am
RNS
Total Voting Rights
01 Jul 2015 8:54 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Blocklisting Interim Review
  7:00 am
RNS
Total Voting Rights
30 Jun 2015 9:13 am
RNS
Director/PDMR Shareholding
25 Jun 2015 3:40 pm
RNS
Oxford BioMedica Block listing Application
23 Jun 2015 12:00 pm
RNS
OXB to present at JMP Securities
19 Jun 2015 10:26 am
RNS
Director/PDMR Shareholding
17 Jun 2015 1:21 pm
RNS
Director/PDMR Shareholding
16 Jun 2015 2:03 pm
RNS
Director/PDMR Shareholding
15 Jun 2015 11:23 am
RNS
Director/PDMR Shareholding
  11:22 am
RNS
Director/PDMR Shareholding
  11:20 am
RNS
Director/PDMR Shareholding
11 Jun 2015 1:01 pm
RNS
Directors' Interest in Share Options
10 Jun 2015 12:09 pm
RNS
Director/PDMR Shareholding
09 Jun 2015 3:13 pm
RNS
Oxford BioMedica plc Director's Share Purchase
  2:56 pm
RNS
Director/PDMR Shareholding
01 Jun 2015 7:00 am
RNS
Total Voting Rights
22 May 2015 7:00 am
RNS
Director/PDMR Shareholding
20 May 2015 7:00 am
RNS
Director/PDMR Shareholding
08 May 2015 7:00 am
RNS
Deferred Bonus Plan
07 May 2015 1:02 pm
RNS
Result of AGM
  12:37 pm
RNS
Appointment of Non-Executive Director
  7:00 am
RNS
Interim Management Statement
05 May 2015 7:02 am
RNS
Presentation of RetinoStat? results
  7:02 am
RNS
Summary of ProSavin? data
01 May 2015 7:00 am
RNS
Secures $50 million loan with Oberland Capital
  7:00 am
RNS
Total Voting Rights
02 Apr 2015 3:40 pm
RNS
2014 Annual Report and Accounts & AGM Notification
01 Apr 2015 4:43 pm
RNS
Holding(s) in Company
  12:27 pm
RNS
Oxford BioMedica Total Voting Rights
20 Mar 2015 7:00 am
RNS
OXB Present at 3rd Annual Regen Med Investor Day
16 Mar 2015 8:59 am
RNS
Oxford BioMedica plc Director's Share Purchase
13 Mar 2015 7:00 am
RNS
Preliminary Results
06 Mar 2015 7:00 am
RNS
Notice of Preliminary Results
05 Mar 2015 9:02 am
RNS
Announces Presentation at Annual ROTH Conference
03 Mar 2015 7:00 am
RNS
Credit Suisse's Global Healthcare Conference
  7:00 am
RNS
Total Voting Rights
23 Feb 2015 3:36 pm
RNS
Chief Secretary to the Treasury visits OXB
16 Feb 2015 11:41 am
RNS
Change of Registered Address
30 Jan 2015 10:47 am
RNS
Total Voting Rights
28 Jan 2015 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
31 Dec 2014 7:00 am
RNS
BLOCK LISTING RETURN
  7:00 am
RNS
Total Voting Rights
18 Dec 2014 2:45 pm
RNS
Director's Share Purchase.
  7:00 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16 Dec 2014 3:50 pm
RNS
Director PDMR Shareholding
  3:50 pm
RNS
Notification Of Major Interest In Shares
01 Dec 2014 7:00 am
RNS
Oxford BioMedica plc Director's Share Purchase
28 Nov 2014 7:00 am
RNS
Total Voting Rights
26 Nov 2014 7:00 am
RNS
Director Dealings
03 Nov 2014 7:00 am
RNS
Interim Management Statement
31 Oct 2014 7:00 am
RNS
Total Voting Rights
17 Oct 2014 9:27 am
RNS
Director's Interest in Share Options
  9:10 am
RNS
Holding(s) in Company
16 Oct 2014 4:52 pm
RNS
Directorate Change
15 Oct 2014 5:05 pm
RNS
Holding(s) in Company
14 Oct 2014 7:00 am
RNS
Oxford BioMedica plc Director's Share Purchase
13 Oct 2014 7:00 am
RNS
Oxford BioMedica Acquires Windrush Court Office
10 Oct 2014 7:41 am
RNS
Additional Listing
  7:00 am
RNS
Second major agreement with Novartis
28 Aug 2014 7:00 am
RNS
Half Yearly Report
15 Aug 2014 7:00 am
RNS
Paul Blake Appointed as Chief Development Officer
07 Aug 2014 7:00 am
RNS
Notice of Results
25 Jul 2014 9:48 am
RNS
Block listing Application
01 Jul 2014 10:55 am
RNS
Oxford BioMedica plc Director's Share Purchase
30 Jun 2014 7:00 am
RNS
Total Voting Rights Update
23 Jun 2014 7:00 am
RNS
Directors' Interest in Share Options
20 Jun 2014 2:38 pm
RNS
Piper Jaffray GenomeRx Symposium in New York
19 Jun 2014 9:50 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
  7:01 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
  7:00 am
RNS
GRANT OF AWARDS
18 Jun 2014 11:30 am
RNS
Loan Repayment in Full
  9:36 am
RNS
Holding(s) in Company
  7:00 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16 Jun 2014 12:29 pm
RNS
RESULT OF GENERAL MEETING AND DIRECTORS DEALING
  7:00 am
RNS
Results of firm fundraising and open offer
03 Jun 2014 12:34 pm
RNS
Result of AGM
29 May 2014 4:52 pm
RNS
Notice of posting of prospectus
  7:00 am
RNS
Fundraising and Open Offer
22 May 2014 9:22 am
RNS
Director Declaration
13 May 2014 7:00 am
RNS
Interim Management Statement
02 May 2014 4:57 pm
RNS
2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30 Apr 2014 7:00 am
RNS
?2.2 Million Grant Received from TSB
29 Apr 2014 7:00 am
RNS
Oxford BioMedica provides update on RetinoStat?
10 Apr 2014 7:00 am
RNS
Final Results
07 Apr 2014 7:00 am
RNS
OXB completes patient recruitment into RetinoStat
03 Apr 2014 7:00 am
RNS
Notice of Results
21 Mar 2014 7:00 am
RNS
OXB Present at Regen Med Investor Day
17 Feb 2014 7:00 am
RNS
Oxford BioMedica and Sanofi Amend Terms for Ocular
17 Jan 2014 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
10 Jan 2014 7:00 am
RNS
Publication of ProSavin Phase I/II Study
09 Jan 2014 12:19 pm
RNS
Oxford BioMedica to Present at Biotech Showcase
06 Jan 2014 10:28 am
RNS
Oxford Biomedica PLC - General Meeting
18 Dec 2013 7:00 am
RNS
OXB option agreement with GSK
11 Dec 2013 7:00 am
RNS
CIRCULAR & GENERAL MEETING NOTIFICATION
22 Nov 2013 12:38 pm
RNS
Director/PDMR Shareholding
19 Nov 2013 7:00 am
RNS
?5 million Loan Facility from Lead Shareholder
  7:00 am
RNS
Interim Management Statement
17 Oct 2013 7:00 am
RNS
Agreement to Resume Clinical Trials
19 Sep 2013 7:00 am
RNS
Director/PDMR Shareholding
17 Sep 2013 1:06 pm
RNS
Block Listing Return
12 Sep 2013 11:18 am
RNS
Oxford BioMedica plc Director's Share Purchase
11 Sep 2013 1:01 pm
RNS
Oxford BioMedica Wins Significant Funding
06 Sep 2013 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
29 Aug 2013 4:08 pm
RNS
TR1 Form
  7:00 am
RNS
Interim Results 2013
28 Aug 2013 7:00 am
RNS
US$1 million Milestone Payment from Pfizer
14 Aug 2013 1:00 pm
RNS
Announced as Funding Competition Winner
29 Jul 2013 7:00 am
RNS
Publication of TroVax Phase II Analyses
23 Jul 2013 7:00 am
RNS
Notice of Interim Results
16 Jul 2013 11:20 am
RNS
Director/PDMR Shareholding
01 Jul 2013 7:00 am
RNS
Update on Glaucoma-GT
28 Jun 2013 7:00 am
RNS
Total Voting Rights
20 Jun 2013 11:15 am
RNS
Director/PDMR Shareholding
19 Jun 2013 11:00 am
RNS
TR-1: Notification of Major Interest in Shares
12 Jun 2013 7:00 am
RNS
Directors' Interests in Share Options
10 Jun 2013 12:59 pm
RNS
Director/PDMR Shareholding
  12:59 pm
RNS
TR-1: Notification of Major Interest in Shares
  7:00 am
RNS
Director's Share Purchase
06 Jun 2013 11:45 am
RNS
Result of AGM
  7:00 am
RNS
Change of Adviser and Broker
  7:00 am
RNS
Management and Board change
05 Jun 2013 10:43 am
RNS
TR-1: Notification of Major Interest in Shares
24 May 2013 10:00 am
RNS
BLOCK LISTING RETURN
16 May 2013 7:00 am
RNS
Interim Management Statement
09 May 2013 9:00 am
RNS
Update from ARVO 2013
03 May 2013 2:00 pm
RNS
Holding(s) in Company
  2:00 pm
RNS
Director/PDMR Shareholding
01 May 2013 7:03 am
RNS
Collaboration with Novartis
17 Apr 2013 1:00 pm
RNS
2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATION
07 Mar 2013 7:00 am
RNS
Initiation of PII Collaborative Study for TroVax
27 Feb 2013 7:00 am
RNS
Preliminary Results
25 Jan 2013 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
23 Jan 2013 7:00 am
RNS
Notice of Preliminary Results
29 Nov 2012 7:00 am
RNS
Exercise of Option by ImaginAb
28 Nov 2012 7:00 am
RNS
Block Listing Return
20 Nov 2012 7:00 am
RNS
Ocular Clinical Programme Update
14 Nov 2012 7:00 am
RNS
Interim Management Statement
09 Nov 2012 7:00 am
RNS
Issue of Key US Patent
10 Oct 2012 7:00 am
RNS
Update on TroVax (R) Development Strategy
03 Oct 2012 7:00 am
RNS
Board Change
27 Sep 2012 8:00 am
RNS
Collaboration With Immune Design Corp.
26 Sep 2012 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
14 Sep 2012 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
10 Sep 2012 12:20 pm
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31 Aug 2012 7:00 am
RNS
Interim Results
29 Aug 2012 2:00 pm
RNS
Oxford BioMedica to Present at Conference
10 Aug 2012 11:06 am
RNS
Block Listing Return
08 Aug 2012 8:00 am
RNS
Positive DSMB Review of Ongoing Clinical Studies
30 Jul 2012 11:59 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27 Jul 2012 9:44 am
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
26 Jul 2012 5:26 pm
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
25 Jul 2012 11:47 am
RNS
Result of EGM
  7:00 am
RNS
Notice of Interim Results
  7:00 am
RNS
Results of Firm Placing and Open Offer
23 Jul 2012 7:00 am
RNS
Funding Award for UshStat(R) Phase I/IIa study
19 Jul 2012 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
10 Jul 2012 7:00 am
RNS
Initiation of Phase II Collaborative Study
06 Jul 2012 1:02 pm
RNS
Notice of posting of prospectus
02 Jul 2012 7:00 am
RNS
Directors' Interest in Shares and Share Options
29 Jun 2012 7:00 am
RNS
Proposed Firm Placing and Open Offer
  7:00 am
RNS
US$3 million Option Exercise Payment from Sanofi
21 Jun 2012 11:31 am
RNS
Holding(s) in Company
08 Jun 2012 7:00 am
RNS
MHRA Approval for Manufacturing Facility
07 Jun 2012 3:00 pm
RNS
Result of AGM
11 May 2012 7:00 am
RNS
Interim Management Statement
08 May 2012 7:00 am
RNS
Presentation of Ocular Clinical Data at ARVO
27 Apr 2012 12:30 pm
RNS
2011 Annual Report and Accounts & AGM Notification
17 Apr 2012 2:00 pm
RNS
Annual Information Update
16 Apr 2012 7:00 am
RNS
Successful Completion of Phase I/II Study
22 Mar 2012 9:57 am
RNS
TR-1 Notification of Major Interest in Shares
12 Mar 2012 7:00 am
RNS
SIGNIFICANT SHAREHOLDING
08 Mar 2012 7:00 am
RNS
Director / PDMR dealings
06 Mar 2012 7:00 am
RNS
Preliminary Results
24 Feb 2012 7:00 am
RNS
Notice of Results
10 Feb 2012 7:00 am
RNS
Management and Board change
30 Jan 2012 11:51 am
RNS
Notification of Major Interest in Shares
16 Dec 2011 7:00 am
RNS
Directors' Interest in Shares
15 Dec 2011 7:00 am
RNS
Interim Update on ProSavin? Phase I/II Study
05 Dec 2011 4:35 pm
RNS
Price Monitoring Extension
28 Nov 2011 7:00 am
RNS
Block Listing Six Monthly Return
16 Nov 2011 7:00 am
RNS
Interim Management Statement
18 Oct 2011 7:00 am
RNS
US IND Approval for Novel Ocular Product
04 Oct 2011 4:39 pm
RNS
TR1 Form
  4:32 pm
RNS
TR1 Form
31 Aug 2011 9:00 am
RNS
TR-1: Notification of Major Interest in Shares
  8:18 am
RNS
Interim Results- Replacement
04 Aug 2011 4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim Data from ProSavin? Phase I/II Study
08 Jul 2011 9:12 am
RNS
Holding(s) in Company
28 Jun 2011 7:00 am
RNS
Notice of Results
07 Jun 2011 7:00 am
RNS
Research Agreement with ImaginAb
26 May 2011 7:00 am
RNS
Block Listing Six Monthly Return
24 May 2011 7:00 am
RNS
Management and Board Changes
23 May 2011 7:00 am
RNS
NEW CLINICAL DATA FROM PROSAVIN? PHASE I/II STUDY
19 May 2011 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
18 May 2011 7:00 am
RNS
Interim Management Statement
05 May 2011 12:54 pm
RNS
Annual General Meeting and Board Changes
04 May 2011 7:00 am
RNS
Pfizer License Extension
03 May 2011 7:00 am
RNS
Announcement of Data in ProSavin Study
15 Apr 2011 1:04 pm
RNS
Directors' Interest in Shares and Share Options
14 Apr 2011 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Apr 2011 10:28 am
RNS
Annual Information Update
31 Mar 2011 7:12 am
RNS
Annual Report and Accounts & AGM Notification
22 Mar 2011 7:00 am
RNS
Director/PDMR Shareholding
21 Mar 2011 7:01 am
RNS
Directorate Change
  7:00 am
RNS
StarGen US IND Approval
02 Mar 2011 7:00 am
RNS
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2010
09 Feb 2011 7:00 am
RNS
Appointment of Head of Manufa
31 Jan 2011 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:20 pm
RNS
Total Voting Rights Update
  12:19 pm
RNS
Notification of Major Interes
  7:00 am
RNS
Acquisition of Manufacturing
20 Jan 2011 7:00 am
RNS
Notice of Preliminary Results
12 Jan 2011 8:20 am
RNS
Holding in Company
10 Jan 2011 8:47 am
RNS
Directors' Interest in Shares
07 Jan 2011 11:30 am
RNS
Result of General Meeting
  7:00 am
RNS
Result of Open Offer
23 Dec 2010 12:00 pm
RNS
Presentation at J.P. Morgan H
22 Dec 2010 7:00 am
RNS
ProSavin Phase I/II Update
14 Dec 2010 7:22 am
RNS
Publication of Prospectus
13 Dec 2010 4:50 pm
RNS
Re Proposed Fundraising
  7:47 am
RNS
Proposed Fundraising
26 Nov 2010 7:00 am
RNS
BLOCK LISTING SIX MONTHLY RET
09 Nov 2010 7:00 am
RNS
US IND APPROVAL FOR RETINOSTA
29 Oct 2010 7:00 am
RNS
Oxford Biomedica PLC Interim
26 Oct 2010 4:35 pm
RNS
Price Monitoring Extension
14 Oct 2010 7:00 am
RNS
Publication in Clinical Cance
  7:00 am
RNS
Change of Adviser and Broker
22 Sep 2010 7:00 am
RNS
TROVAX? SELECTED AS ONE OF TO
15 Sep 2010 11:53 am
RNS
Holding(s) in Company
24 Aug 2010 7:00 am
RNS
Half Yearly Report
18 Aug 2010 10:31 am
RNS
Holding(s) in Company
  7:00 am
RNS
Emergent Licensing Agreement
26 Jul 2010 7:00 am
RNS
TroVax Update
01 Jul 2010 7:00 am
RNS
OXB awarded research grant
  7:00 am
RNS
Oxford BioMedica R&D Day
30 Jun 2010 11:59 am
RNS
Total Voting Rights
24 Jun 2010 2:50 pm
RNS
Notice of Interim Results
  7:00 am
RNS
TroVax Mesolthelioma Collabor
18 Jun 2010 7:00 am
RNS
Licence Amendment and Share I
17 Jun 2010 11:38 am
RNS
Holding(s) in Company
15 Jun 2010 3:32 pm
RNS
Director/PDMR Shareholding
14 Jun 2010 7:00 am
RNS
TWO-YEAR PHASE I/II RESULTS O
27 May 2010 10:28 am
RNS
BLOCK LISTING SIX MONTHLY RET
19 May 2010 7:00 am
RNS
Interim Management Statement
13 May 2010 7:00 am
RNS
OXB to present at the Rodman
05 May 2010 11:39 am
RNS
Notification of Major Interes
04 May 2010 10:23 am
RNS
Total Voting Rights Update
27 Apr 2010 12:46 pm
RNS
Annual General Meeting
21 Apr 2010 7:00 am
RNS
Board Change
09 Apr 2010 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
01 Apr 2010 3:54 pm
RNS
Annual Information Update
31 Mar 2010 12:16 pm
RNS
Total Voting Rights Update
29 Mar 2010 5:27 pm
RNS
2009 ANNUAL REPORT AND ACCOUN
10 Mar 2010 7:00 am
RNS
Preliminary Results
26 Feb 2010 9:14 am
RNS
Total Voting Rights Update
17 Feb 2010 10:10 am
RNS
Notice of Results
29 Jan 2010 11:28 am
RNS
Total Voting Rights
27 Jan 2010 1:00 pm
RNS
Collaboration extension
  7:00 am
RNS
Global settlement
22 Jan 2010 7:00 am
RNS
Licence agreement
20 Jan 2010 7:00 am
RNS
European Orphan Drug Designat
05 Jan 2010 7:00 am
RNS
Management and Board Changes
15 Dec 2009 7:00 am
RNS
EU orphan drug designation
11 Dec 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
03 Dec 2009 7:00 am
RNS
Holding(s) in Company
27 Nov 2009 12:16 pm
RNS
Block Listing Six Monthly Ret
19 Nov 2009 7:00 am
RNS
Interim Management Statement
30 Oct 2009 11:37 am
RNS
Total Voting Rights Update
19 Oct 2009 2:14 pm
RNS
Holding(s) in Company
15 Oct 2009 7:00 am
RNS
Prosavin Update
14 Oct 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
08 Oct 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
30 Sep 2009 10:50 am
RNS
Total Voting Rights Update
22 Sep 2009 7:00 am
RNS
Phase III Trist Study of Trov
04 Sep 2009 7:00 am
RNS
Rodman & Renshaw Conference
01 Sep 2009 7:00 am
RNS
Director's Interest in Shares
28 Aug 2009 3:59 pm
RNS
Total Voting Rights Update
27 Aug 2009 7:00 am
RNS
Interim Results
19 Aug 2009 7:00 am
RNS
Trovax Presentation at ECCO 1
07 Aug 2009 7:00 am
RNS
Canaccord Adams Global Growth
06 Aug 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Time change of Analyst briefi
05 Aug 2009 7:00 am
RNS
Notice of Interim Results
13 Jul 2009 7:00 am
RNS
ProSavin PhI/II study
09 Jul 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
06 Jul 2009 7:00 am
RNS
Outcome of FDA review and Tro
02 Jul 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
23 Jun 2009 4:35 pm
RNS
Price Monitoring Extension
19 Jun 2009 9:21 am
RNS
Major Interest in Shares - Am
18 Jun 2009 4:25 pm
RNS
Major Interest in Shares
  7:00 am
RNS
Piper Jaffray Europe Conferen
10 Jun 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
05 Jun 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Jun 2009 12:25 pm
RNS
Result of Annual General Meet
01 Jun 2009 4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
UPDATED TROVAX? PHASE I/II AN
29 May 2009 10:17 am
RNS
Total Voting Rights Update
28 May 2009 2:10 pm
RNS
Block Listing Six Monthly Ret
14 May 2009 7:00 am
RNS
Interim Management Statement
11 May 2009 7:00 am
RNS
Bavarian Nordic's re-filed la
01 May 2009 5:06 pm
RNS
Notification of Shares
29 Apr 2009 7:00 am
RNS
NEW COLLABORATION
  7:00 am
RNS
RIGHTS REGAINED TO TROVAX?
17 Apr 2009 12:08 pm
RNS
Major Interest in Shares
14 Apr 2009 3:26 pm
RNS
Major Interest in Shares
03 Apr 2009 4:06 pm
RNS
Annual Information Update
31 Mar 2009 11:12 am
RNS
08 Annual Report and Accounts
25 Mar 2009 5:00 pm
RNS
Directors' Interest in Shares
23 Mar 2009 2:06 pm
RNS
Major Interest in Shares
20 Mar 2009 2:51 pm
RNS
Major Interest in Shares
12 Mar 2009 7:00 am
RNS
Preliminary Results
10 Mar 2009 9:29 am
RNS
Major Interests in Shares
04 Mar 2009 2:10 pm
RNS
Major Interests in Shares
27 Feb 2009 11:13 am
RNS
Total Voting Rights Update
25 Feb 2009 7:00 am
RNS
Notice of Results
05 Feb 2009 7:00 am
RNS
Further investment
29 Jan 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
27 Jan 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:54 pm
RNS
Response to re-filed US litig
26 Jan 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
19 Jan 2009 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
12 Jan 2009 4:35 pm
RNS
Price Monitoring Extension
  9:55 am
RNS
Dismissal of Patent Infringem
07 Jan 2009 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
22 Dec 2008 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
19 Dec 2008 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
16 Dec 2008 4:35 pm
RNS
Price Monitoring Extension
15 Dec 2008 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
03 Dec 2008 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
28 Nov 2008 10:44 am
RNS
Block Listing Six Monthly Ret
25 Nov 2008 4:50 pm
RNS
Second Price Monitoring Extn
  4:45 pm
RNS
Price Monitoring Extension
24 Nov 2008 4:52 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
21 Nov 2008 4:50 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
20 Nov 2008 4:45 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
19 Nov 2008 7:00 am
RNS
Positive results in Phase I/I
18 Nov 2008 4:43 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim Management Statement
17 Nov 2008 4:41 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
14 Nov 2008 4:42 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
PRESENTATIONS OF PROSAVIN?
11 Nov 2008 4:45 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
07 Nov 2008 7:00 am
RNS
Renshaw Healthcare Conference
06 Nov 2008 4:47 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
03 Nov 2008 4:45 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
31 Oct 2008 4:39 pm
RNS
Price Monitoring Extension
29 Oct 2008 4:43 pm
RNS
Second Price Monitoring Extn
  4:42 pm
RNS
Price Monitoring Extension
27 Oct 2008 4:47 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
24 Oct 2008 4:44 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
TroVax Phase I and II data
23 Oct 2008 4:43 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
22 Oct 2008 4:45 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
14 Oct 2008 4:44 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Major Interest in Shares
13 Oct 2008 4:42 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Board Appointment
08 Oct 2008 4:45 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
07 Oct 2008 7:00 am
RNS
FDA AGREEMENT ON TROVAX? PHAS
29 Sep 2008 4:43 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
26 Sep 2008 4:35 pm
RNS
Price Monitoring Extension
18 Sep 2008 7:00 am
RNS
UBS Global Life Sciences Conf
10 Sep 2008 3:10 pm
RNS
Director Shareholding
09 Sep 2008 7:00 am
RNS
Interim data for ProSavin
08 Sep 2008 4:42 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
03 Sep 2008 7:00 am
RNS
Offer Update
02 Sep 2008 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:12 pm
CIS
Rule 8.3 - OXFORD BIOMEDICA
01 Sep 2008 2:04 pm
CIS
Rule 8.3 - OXFORD BIOMEDICA
29 Aug 2008 7:00 am
RNS
Board Change
  7:00 am
RNS
Interim Results
27 Aug 2008 4:33 pm
RNS
Notice of Interim Results
22 Aug 2008 3:10 pm
RNS
Rule 8.3- Oxford Biomedica PL
20 Aug 2008 2:39 pm
CIS
Rule 8.3 - OXFORD BIOMEDICA
  11:27 am
RNS
GENETHERA POTENTIAL OFFER FOR
18 Aug 2008 10:21 am
RNS
Notification of Major Interes
15 Aug 2008 1:19 pm
RNS
Rule 2.10 Announcement
  11:38 am
RNS
Rejection of GeneThera's indi
28 Jul 2008 7:00 am
RNS
Board Appointment
15 Jul 2008 4:13 pm
RNS
TROVAX Phase III TRIST Study
14 Jul 2008 8:48 am
RNS
TroVax QUASAR Trial
11 Jul 2008 7:00 am
RNS
RECOMMENDATION FOR TROVAX? PH
01 Jul 2008 9:10 am
RNS
RESPONSE TO BAVARIAN NORDIC'S
  7:00 am
RNS
Board Changes
24 Jun 2008 7:00 am
RNS
JEFFERIES HEALTHCARE CONFEREN
02 Jun 2008 7:00 am
RNS
Trovax Phase II Trial Results
30 May 2008 3:28 pm
RNS
Blocklisting Return
  3:25 pm
RNS
Total Voting Rights Update
27 May 2008 10:25 am
RNS
FBR Capital Markets Spring In
19 May 2008 7:00 am
RNS
Rodman & Renshaw Healthcare C
16 May 2008 7:00 am
RNS
Phase II Trial Results
09 May 2008 1:48 pm
RNS
Annual General Meeting
  7:00 am
RNS
Interim Management Statement
30 Apr 2008 11:42 am
RNS
Total Voting Rights
15 Apr 2008 7:00 am
RNS
Board changes
03 Apr 2008 8:35 am
RNS
Annual Information Update
01 Apr 2008 4:18 pm
RNS
Major Interest in Shares
31 Mar 2008 10:48 am
RNS
Total Voting Rights Update
25 Mar 2008 10:06 am
RNS
New Trovax Clinical Data
18 Mar 2008 9:09 am
RNS
Major Interest in Shares
17 Mar 2008 12:32 pm
RNS
Presentation at Conference
13 Mar 2008 12:26 pm
RNS
Directors' Interest in Shares
10 Mar 2008 8:52 am
RNS
Board Appointment
  7:02 am
RNS
Phase III Trist Study
  7:01 am
RNS
Preliminary Results
29 Feb 2008 11:43 am
RNS
Total Voting Rights Update
20 Feb 2008 7:00 am
RNS
Phase III Trist Study
19 Feb 2008 4:22 pm
RNS
Holding(s) in Company
15 Feb 2008 9:05 am
RNS
Major Interest In Shares
13 Feb 2008 12:15 pm
RNS
Major Interest in Shares
07 Feb 2008 7:00 am
RNS
Notification of Results
01 Feb 2008 10:40 am
RNS
Notification of Shares
31 Jan 2008 8:57 am
RNS
Total Voting Rights
30 Jan 2008 8:00 am
RNS
Notifcation of Shares
23 Jan 2008 9:16 am
RNS
Major Interest in Shares
22 Jan 2008 7:00 am
RNS
Development Milestone
18 Jan 2008 12:53 pm
RNS
Notification of Shares
07 Jan 2008 7:00 am
RNS
Exclusive License Agreement
18 Dec 2007 1:35 pm
RNS
Interest In Shares
13 Dec 2007 7:00 am
RNS
Phase I/II Trial
10 Dec 2007 12:28 pm
RNS
Major Interest in Shares
  7:00 am
RNS
Trovax Phase III Trial
05 Dec 2007 1:33 pm
RNS
Scrip's Deal of the year
29 Nov 2007 10:51 am
RNS
techMARK Award
16 Nov 2007 11:18 am
RNS
Block Listing
09 Nov 2007 7:00 am
RNS
Broker Announcement
26 Oct 2007 7:01 am
RNS
Patent Infringement Dispute
25 Oct 2007 11:27 am
RNS
Director/PDMR Shareholding
  7:01 am
RNS
Business Update
22 Oct 2007 2:57 pm
RNS
Director Shareholdings
28 Sep 2007 3:25 pm
RNS
Holding(s) in Company
11 Sep 2007 7:00 am
RNS
Milestone in Trovax
  7:00 am
RNS
Interim Results
31 Aug 2007 3:39 pm
RNS
Holding(s) in Company
  10:26 am
RNS
TVR Update
30 Aug 2007 9:10 am
RNS
Holding(s) in Company
07 Aug 2007 7:00 am
RNS
Notice of Results
03 Aug 2007 4:33 pm
RNS
Holding(s) in Company
02 Aug 2007 3:38 pm
RNS
Holding(s) in Company
  7:02 am
RNS
Phase II Clinical Trial Data
31 Jul 2007 3:05 pm
RNS
Total Voting Rights
25 Jul 2007 7:00 am
RNS
DSMB Interim Analysis-TroVax
06 Jul 2007 7:00 am
RNS
License Agreement
02 Jul 2007 7:00 am
RNS
Lentivector Licence
29 Jun 2007 4:17 pm
RNS
Total Voting Rights
28 Jun 2007 12:39 pm
RNS
Holding(s) in Company
  12:29 pm
RNS
Notification of Interest
22 Jun 2007 12:43 pm
RNS
Viragen Update
18 Jun 2007 7:01 am
RNS
Health Care Conference
  7:00 am
RNS
Holding(s) in Company
04 Jun 2007 7:01 am
RNS
Phase II Trovax data at ASCO
31 May 2007 5:38 pm
RNS
Total Voting Rights Update
29 May 2007 7:01 am
RNS
ASCO data
24 May 2007 7:01 am
RNS
FBR Growth Conference
22 May 2007 3:53 pm
RNS
Holding(s) in Company
17 May 2007 1:23 pm
RNS
Blocklisting 6 monthly return
  7:00 am
RNS
Phase II Date @ AAI Meeting
08 May 2007 7:01 am
RNS
Development of OVA System
03 May 2007 11:59 am
RNS
AGM 2007
01 May 2007 7:01 am
RNS
Preclinical data
30 Apr 2007 4:07 pm
RNS
TVR update
  4:05 pm
RNS
Holding(s) in Company
  7:01 am
RNS
Director/PDMR Shareholding
17 Apr 2007 4:02 pm
RNS
Annual Information Update
05 Apr 2007 3:29 pm
RNS
Holding(s) in Company
03 Apr 2007 4:30 pm
RNS
Director/PDMR Shareholding
30 Mar 2007 2:32 pm
RNS
Total Voting Rights
29 Mar 2007 2:30 pm
RNS
Notice of AGM
28 Mar 2007 7:01 am
RNS
Agreement to develop Trovax
20 Mar 2007 6:05 pm
RNS
Holding(s) in Company
16 Mar 2007 5:31 pm
RNS
Holding(s) in Company
  1:35 pm
RNS
Holding(s) in Company
15 Mar 2007 8:42 am
RNS
Acquisition
12 Mar 2007 7:01 am
RNS
Acq of Oxxon Therapeutics
06 Mar 2007 7:00 am
RNS
Preliminary Results
28 Feb 2007 11:15 am
RNS
Total Voting Rights
27 Feb 2007 11:12 am
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of FY2006 Results
22 Feb 2007 9:36 am
RNS
Holding(s) in Company
20 Feb 2007 12:45 pm
RNS
Holding(s) in Company
14 Feb 2007 11:04 am
RNS
Holding(s) in Company
09 Feb 2007 10:55 am
RNS
Holding(s) in Company
07 Feb 2007 5:49 pm
RNS
Holding(s) in Company
01 Feb 2007 3:18 pm
RNS
Result of EGM
31 Jan 2007 6:04 pm
RNS
Total Voting Rights
24 Jan 2007 3:39 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Transgenic Milestone
16 Jan 2007 7:01 am
RNS
Publication of Results
10 Jan 2007 7:00 am
RNS
Phase III Trial of Trovax
04 Jan 2007 4:48 pm
RNS
Total Voting Rights-Amendment
02 Jan 2007 3:47 pm
RNS
Total Voting Rights-Amendment
22 Dec 2006 11:55 am
RNS
Total Voting Rights
21 Dec 2006 7:00 am
RNS
GSK Lentivector Licence
19 Dec 2006 5:51 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Licensing Agreement
08 Dec 2006 4:55 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Positive Opinion on Trovax
05 Dec 2006 7:00 am
RNS
Holding(s) in Company
21 Nov 2006 9:31 am
RNS
Blocklisting Interim Review
13 Nov 2006 7:00 am
RNS
Prosavin preclinical data
09 Nov 2006 7:00 am
RNS
Phase II Results - Trovax
07 Nov 2006 7:00 am
RNS
Phase III Trial in Trovax
06 Oct 2006 7:00 am
RNS
Presentation at Conference
02 Oct 2006 7:00 am
RNS
Gene Therapy for Blindness
25 Sep 2006 2:32 pm
RNS
Holding(s) in Company
20 Sep 2006 10:08 am
RNS
Holding(s) in Company
07 Sep 2006 10:54 am
RNS
Interest in Share Options
05 Sep 2006 7:01 am
RNS
SWOG in phase 2 Trovax trial
  7:00 am
RNS
Interim Results
21 Aug 2006 7:00 am
RNS
Trovax at Cancer Conference
03 Aug 2006 4:00 pm
RNS
Holding(s) in Company
02 Aug 2006 7:00 am
RNS
Notice of Interim Results
31 Jul 2006 7:00 am
RNS
Trovax Update & Clarification
18 Jul 2006 4:09 pm
RNS
Holding(s) in Company
06 Jul 2006 4:31 pm
RNS
Holding(s) in Company
05 Jul 2006 4:54 pm
RNS
Director/PDMR Shareholding
26 Jun 2006 11:43 am
RNS
Holding(s) in Company
  7:00 am
RNS
Prosavin Patent
21 Jun 2006 7:00 am
RNS
Piper Jaffray Health Care
12 Jun 2006 4:00 pm
RNS
Holding(s) in Company
07 Jun 2006 7:00 am
RNS
Phase II results - TROVAX
23 May 2006 7:00 am
RNS
Phase II Trial Trovax
22 May 2006 4:30 pm
RNS
Holding(s) in Company
18 May 2006 7:00 am
RNS
Blocklisting Interim Review
16 May 2006 8:51 am
RNS
Director/PDMR Shareholding
12 May 2006 7:00 am
RNS
Agreement with FDA
04 May 2006 11:53 am
RNS
Annual General Meeting 06
02 May 2006 7:01 am
RNS
RETINOSTAT
20 Apr 2006 5:38 pm
RNS
Holding(s) in Company
11 Apr 2006 4:26 pm
RNS
Annual Report and Accounts
  8:21 am
RNS
Annual Information Update
06 Apr 2006 1:23 pm
RNS
Holding(s) in Company
30 Mar 2006 7:01 am
RNS
Clinical Trial Results
24 Mar 2006 12:40 pm
RNS
Holding(s) in Company
23 Mar 2006 11:03 am
RNS
Director/PDMR Shareholding
16 Mar 2006 4:04 pm
RNS
Director/PDMR Shareholding
14 Mar 2006 7:00 am
RNS
Preliminary Results
10 Mar 2006 7:00 am
RNS
VIRxSYS Corporation Licence
23 Feb 2006 7:00 am
RNS
Notice of Results
03 Feb 2006 9:48 am
RNS
Board Appointment
26 Jan 2006 9:46 am
RNS
Holding(s) in Company
24 Jan 2006 8:44 am
RNS
Holding(s) in Company
18 Jan 2006 4:13 pm
RNS
Viragen Milestone
04 Jan 2006 10:12 am
RNS
Holding(s) in Company
20 Dec 2005 4:42 pm
RNS
Holding(s) in Company
19 Dec 2005 5:10 pm
RNS
Holding in Company Correction
  4:55 pm
RNS
Holding(s) in Company
16 Dec 2005 1:45 pm
RNS
Director/PDMR S/hldg-Amend
15 Dec 2005 9:00 am
RNS
Director/PDMR Shareholding
12 Dec 2005 12:34 pm
RNS
Holding(s) in Company
  11:24 am
RNS
Result of EGM
09 Dec 2005 11:43 am
RNS
Holding(s) in Company
08 Dec 2005 3:31 pm
RNS
Holding(s) in Company
24 Nov 2005 11:37 am
RNS
Holding(s) in Company
22 Nov 2005 4:12 pm
RNS
Blocklisting Interim Review
  12:17 pm
RNS
Holding(s) in Company
  7:00 am
RNS
TroVax Notice of Allowance
17 Nov 2005 9:35 am
RNS
Holding(s) in Company
16 Nov 2005 4:20 pm
RNS
Publication of Prospectus
  7:01 am
RNS
Phase II trial with TroVax
  7:01 am
RNS
Placing and Open Offer
15 Nov 2005 11:54 am
RNS
Holding(s) in Company
02 Nov 2005 2:22 pm
RNS
Trovax & Proposed Fundraising
24 Oct 2005 1:49 pm
RNS
Trovax Clarification
  7:00 am
RNS
Licence Agreement
20 Oct 2005 7:00 am
RNS
Agreement with Sigma-Aldrich
19 Oct 2005 7:00 am
RNS
Wyeth Preclinical Data
18 Oct 2005 11:30 am
RNS
Additional Phase II Data
17 Oct 2005 7:00 am
RNS
Final Phase II Results
06 Oct 2005 7:00 am
RNS
Prelim Phase II Results
03 Oct 2005 1:54 pm
RNS
Change of Adviser
28 Sep 2005 5:55 pm
RNS
Holding(s) in Company
20 Sep 2005 7:00 am
RNS
Interim Results
16 Sep 2005 6:22 pm
RNS
Holding(s) in Company
07 Sep 2005 7:01 am
RNS
Appointment
05 Sep 2005 7:00 am
RNS
Notice of Results
25 Aug 2005 2:11 pm
RNS
Holding(s) in Company
18 Aug 2005 10:06 am
RNS
Holding(s) in Company
17 Aug 2005 1:56 pm
RNS
Holding(s) in Company
01 Aug 2005 7:00 am
RNS
Completion of Clinical Trial
25 Jul 2005 7:00 am
RNS
Awarded Research Grant
06 Jul 2005 4:09 pm
RNS
Holding(s) in Company
04 Jul 2005 7:00 am
RNS
Two New Patents Granted
30 Jun 2005 4:00 pm
RNS
Holding(s) in Company
29 Jun 2005 4:00 pm
RNS
Holding(s) in Company
17 Jun 2005 3:21 pm
RNS
Holding(s) in Company
  11:12 am
RNS
Chair Panel at BIO 2005
16 Jun 2005 4:47 pm
RNS
Holding(s) in Company
06 Jun 2005 3:00 pm
RNS
Director Shareholding
  7:00 am
RNS
Licensing Agreement
03 Jun 2005 9:00 am
RNS
Viragen Milestone
  7:00 am
RNS
Innurex ASGT Data
19 May 2005 3:22 pm
RNS
Blocklisting Interim Review
16 May 2005 7:00 am
RNS
Phase II trials of TroVax
12 May 2005 4:00 pm
RNS
Holding(s) in Company
  10:24 am
RNS
2005 ASCO Annual Meeting
10 May 2005 12:05 pm
RNS
AGM Statement
09 May 2005 7:00 am
RNS
European Patent Granted
05 May 2005 7:00 am
RNS
Preclinical Effiancy Data
27 Apr 2005 4:00 pm
RNS
Holding(s) in Company
22 Apr 2005 3:03 pm
RNS
Holding(s) in Company
20 Apr 2005 4:41 pm
RNS
Holding(s) in Company
15 Apr 2005 3:49 pm
RNS
Holding(s) in Company
29 Mar 2005 7:00 am
RNS
Notice of AGM
  7:00 am
RNS
Notice of Allowance
22 Mar 2005 11:42 am
RNS
Director Shareholding
21 Mar 2005 10:51 am
RNS
Exit of Investment
  7:00 am
RNS
Final Results
14 Mar 2005 12:47 pm
RNS
LentiVector Technology
10 Mar 2005 7:00 am
RNS
Presenting at SG Cowen Conf
04 Mar 2005 9:25 am
RNS
Directorate Change
  7:00 am
RNS
Notice of Results
02 Mar 2005 7:00 am
RNS
Results from 3 Phase II Trial
01 Mar 2005 12:17 pm
RNS
Holding(s) in Company
17 Feb 2005 1:54 pm
RNS
Progress Report
07 Feb 2005 7:00 am
RNS
Offer Talks Terminated
01 Feb 2005 7:00 am
RNS
Licensing Agreement
31 Jan 2005 9:18 am
RNS
Holding(s) in Company
28 Jan 2005 7:00 am
RNS
Rule 2.10 Announcement
27 Jan 2005 7:00 am
RNS
Rule 2.10 Announcement
26 Jan 2005 5:39 pm
RNS
Holding(s) in Company
21 Jan 2005 11:26 am
RNS
Holding(s) in Company
  7:00 am
RNS
Rule 2.10 Announcement
20 Jan 2005 7:00 am
RNS
Rule 2.10 Announcement
19 Jan 2005 7:00 am
RNS
Stmnt re Share Price Movement
12 Jan 2005 7:00 am
RNS
Holding(s) in Company
05 Jan 2005 7:00 am
RNS
Agreement with Biogen Idec
16 Dec 2004 7:00 am
RNS
New Preclinical Data
13 Dec 2004 7:00 am
RNS
Licence Agreement
19 Nov 2004 2:15 pm
RNS
Blocklisting Interim Review
01 Nov 2004 4:00 pm
RNS
Holding(s) in Company
29 Oct 2004 7:00 am
RNS
Extended Collaboration
12 Oct 2004 10:37 am
RNS
Director Shareholding
01 Oct 2004 6:06 pm
RNS
Holding(s) in Company
22 Sep 2004 4:00 pm
RNS
Holding(s) in Company
17 Sep 2004 4:06 pm
RNS
Holding(s) in Company
  7:00 am
RNS
License Agreement
02 Sep 2004 4:30 pm
RNS
Holding(s) in Company
01 Sep 2004 7:01 am
RNS
TroVax Phase II Trials
  7:00 am
RNS
Interim Results
24 Aug 2004 9:24 am
RNS
Notice of WebCast
18 Aug 2004 7:00 am
RNS
Appointment of Broker
15 Jul 2004 4:30 pm
RNS
Holding(s) in Company
06 Jul 2004 4:30 pm
RNS
Holding(s) in Company
05 Jul 2004 8:39 am
RNS
License Agreement
30 Jun 2004 9:54 am
RNS
Notice of Results
21 Jun 2004 9:41 am
RNS
Scientific Report
18 Jun 2004 5:00 pm
RNS
Innurex Programme
07 Jun 2004 3:55 pm
RNS
Holding(s) in Company
  12:39 pm
RNS
Acquisition
02 Jun 2004 7:00 am
RNS
Preclinical data
28 May 2004 4:36 pm
RNS
Holding(s) in Company
27 May 2004 7:00 am
RNS
Pioneering Research
21 May 2004 9:17 am
RNS
Blocklisting Interim Review
12 May 2004 4:42 pm
RNS
Holding(s) in Company
  4:16 pm
RNS
Directorate Change
29 Apr 2004 7:00 am
RNS
Regulatory Approval
20 Apr 2004 12:10 pm
RNS
AGM Statement
29 Mar 2004 7:00 am
RNS
Research Update
03 Mar 2004 7:00 am
RNS
Final Results
20 Feb 2004 2:50 pm
RNS
Holding(s) in Company
05 Feb 2004 8:30 am
RNS
LentiVector Update
21 Jan 2004 7:00 am
RNS
Notice of Results
16 Jan 2004 7:00 am
RNS
Update on TroVax
18 Dec 2003 7:00 am
RNS
Research Update
15 Dec 2003 7:33 am
RNS
Product Update
01 Dec 2003 10:56 am
RNS
Holding(s) in Company
27 Nov 2003 7:00 am
RNS
Research Update
24 Nov 2003 9:12 am
RNS
Blocklisting Interim Review
13 Nov 2003 7:00 am
RNS
Preclinical update
10 Nov 2003 5:53 pm
RNS
Holding(s) in Company
05 Nov 2003 8:37 am
RNS
Holding(s) in Company
29 Oct 2003 4:25 pm
RNS
Holding(s) in Company
27 Oct 2003 5:29 pm
RNS
Result of Equity Issue
24 Oct 2003 9:51 am
RNS
Research Update
23 Oct 2003 8:47 am
RNS
Director Shareholding
02 Oct 2003 1:10 pm
RNS
Result of EGM
16 Sep 2003 7:01 am
RNS
Rights Issue
  7:00 am
RNS
Interim Results
09 Sep 2003 7:00 am
RNS
Retinostat Agreement
28 Aug 2003 7:00 am
RNS
Re Joint Venture
20 Aug 2003 7:00 am
RNS
Notice of Results
13 Aug 2003 7:00 am
RNS
LentiVector Patent Update
14 Jul 2003 7:00 am
RNS
TroVax Update
03 Jul 2003 7:00 am
RNS
Research Update
23 Jun 2003 7:00 am
RNS
Update on ProSavin
27 May 2003 3:25 pm
RNS
Blocklisting Interim Review
22 May 2003 10:16 am
RNS
Additional Listing
20 May 2003 7:00 am
RNS
TroVax Update
06 May 2003 7:00 am
RNS
Data on RetinoStat
23 Apr 2003 2:43 pm
RNS
Holding(s) in Company
15 Apr 2003 7:00 am
RNS
AGM Statement
18 Mar 2003 7:00 am
RNS
Option Agreement
04 Mar 2003 7:00 am
RNS
Wyeth Collaboration Update
  7:00 am
RNS
Final Results
03 Mar 2003 7:00 am
RNS
TroVax to Enter Phase II
12 Feb 2003 9:09 am
RNS
Notice of Results
11 Feb 2003 7:00 am
RNS
Grant Awarded
28 Jan 2003 7:00 am
RNS
Joint Programme Agreed
20 Jan 2003 4:01 pm
RNS
Holding(s) in Company
17 Jan 2003 4:47 pm
RNS
Holding(s) in Company
06 Jan 2003 7:00 am
RNS
Research Agreement
17 Dec 2002 11:43 am
RNS
Grant Awarded
25 Nov 2002 7:00 am
RNS
Change of Adviser
14 Nov 2002 10:47 am
RNS
New Appointment
08 Nov 2002 9:00 am
RNS
Update on Clinical Plans
01 Nov 2002 2:12 pm
RNS
Directorate Change
24 Oct 2002 8:59 am
RNS
New Development Partner
19 Sep 2002 3:02 pm
RNS
Director Shareholding
17 Sep 2002 12:16 pm
RNS
Director Shareholding
11 Sep 2002 3:26 pm
RNS
Director Shareholding
29 Aug 2002 3:35 pm
RNS
Director Shareholding
28 Aug 2002 7:00 am
RNS
Interim Results
27 Aug 2002 4:10 pm
RNS
Holding(s) in Company
13 Aug 2002 11:28 am
RNS
Notice of Results
06 Aug 2002 3:48 pm
RNS
Holding(s) in Company
25 Jul 2002 9:23 am
RNS
Re Agreement
11 Jul 2002 7:00 am
RNS
Positive Clinical Trials
27 Jun 2002 3:10 pm
RNS
Holding(s) in Company
25 Jun 2002 7:00 am
RNS
Research Update
10 Jun 2002 7:00 am
RNS
Research Update
06 Jun 2002 7:00 am
RNS
Statement re: product update
08 May 2002 7:00 am
RNS
Re Alliance
01 May 2002 11:57 am
RNS
Directorate Change
20 Mar 2002 4:08 pm
RNS
Annual Report & Accts etc
27 Feb 2002 7:00 am
RNS
Final Results
20 Feb 2002 2:30 pm
RNS
Research Update
22 Jan 2002 11:09 am
RNS
Blocklisting Interim Review
15 Jan 2002 2:57 pm
RNS
Notice of Results
24 Dec 2001 11:57 am
RNS
Director Shareholding
13 Dec 2001 7:00 am
RNS
Research Update/Issue of Shrs
12 Nov 2001 7:00 am
RNS
Research Update
01 Nov 2001 2:52 pm
RNS
Director Shareholding
15 Oct 2001 7:00 am
RNS
Research Update
02 Oct 2001 11:00 am
RNS
Termination of collaboration
12 Sep 2001 9:34 am
RNS
Holding in Company
06 Sep 2001 10:31 am
RNS
Hldg in Co/D. Shareholding
  7:30 am
RNS
Holding in Oxford Biomedica
01 Aug 2001 7:01 am
RNS
Interim Results
27 Jul 2001 4:39 pm
RNS
Notice of Results
10 Jul 2001 10:41 am
RNS
Research Update
26 Jun 2001 1:44 pm
RNS
Statement re Patent
29 May 2001 5:28 pm
RNS
Holding in Company
  2:19 pm
RNS
Director Shareholding
  1:09 pm
RNS
Appointment
02 May 2001 5:56 pm
RNS
Additional Listing
24 Apr 2001 11:02 am
RNS
Re Techmark Index
17 Apr 2001 4:20 pm
RNS
Completion of Fund Raising
  1:55 pm
RNS
Document regarding Listing Particulars
  7:00 am
RNS
Results of EGM &Equity Issues
12 Apr 2001 12:58 pm
RNS
Re:Oxford Biomedica PLC
27 Mar 2001 7:00 am
RNS
Successful patent application
12 Mar 2001 5:10 pm
RNS
Director Shareholding
  7:01 am
RNS
Corporate Action
  7:01 am
RNS
Full List/Placing& Open Offer
14 Feb 2001 3:59 pm
RNS
Additional Listing
13 Feb 2001 10:48 am
RNS
Appointment
05 Feb 2001 7:00 am
RNS
Acquisition of Technology
01 Feb 2001 4:35 pm
RNS
Access to Antibody Technology
26 Jan 2001 7:00 am
RNS
Preliminary Results 2000
22 Jan 2001 7:00 am
RNS
Agreement with AHP Signed
02 Jan 2001 5:13 pm
RNS
Board Appointment
  7:13 am
RNS
TroVax into Clinical Trials
13 Dec 2000 7:00 am
RNS
Collaboration with Valentis
04 Dec 2000 7:00 am
RNS
New Technology Developed
06 Nov 2000 7:00 am
RNS
First Clinical Trials
16 Oct 2000 7:00 am
RNS
Ethical Approval for Trovax
04 Oct 2000 7:00 am
RNS
Net Asset Value
28 Sep 2000 9:53 am
RNS
Director Shareholding
26 Sep 2000 7:30 am
RNS
Bioinformatics Collaboration
23 Aug 2000 11:51 am
RNS
Employee Share Options
17 Aug 2000 4:17 pm
RNS
Additional Listing
16 Aug 2000 7:00 am
RNS
Interim Results 2000
15 Aug 2000 5:48 pm
RNS
Additional Listing
  11:02 am
RNS
Additional Listing
  7:00 am
RNS
Research Update
10 Aug 2000 7:00 am
RNS
Re Successful Fund Raising
08 Aug 2000 12:40 pm
RNS
Additional Listing
07 Aug 2000 1:25 pm
RNS
Statement re Press Comment
26 Jun 2000 8:21 am
RNS
Research Update
06 Jun 2000 7:00 am
RNS
Agreement
18 May 2000 11:05 am
RNS
Agreements Signed, etc
02 May 2000 11:14 am
RNS
Therapeutic Genes for Treatment of Cancer Acquired
31 Mar 2000 1:27 pm
RNS
Directors' Notification of Dealing in Shares
23 Mar 2000 4:29 pm
RNS
Directors' Dealings
21 Mar 2000 11:23 am
RNS
Paul Durrands Appointed as Commercial Director
20 Mar 2000 12:08 pm
RNS
Agreement Signed with Nycomed Amersham Imaging
16 Mar 2000 8:39 am
RNS
Human Genome/Patenting
08 Mar 2000 4:58 pm
RNS
Directors' Dealings
28 Feb 2000 8:19 am
RNS
Gene Therapy Patent Obtained in the USA
24 Feb 2000 7:01 am
RNS
Final Results - Year Ended 31 December 1999
21 Feb 2000 7:01 am
RNS
Deal Signed on Novel Tumour Vaccine
14 Feb 2000 7:02 am
RNS
Collaboration Agreement Signed with AstraZeneca
02 Feb 2000 7:01 am
RNS
Successful Developments in Macrogen Cancer Therapy
24 Jan 2000 2:58 pm
RNS
Response to Press Comment on FDA Ruling
20 Jan 2000 4:13 pm
RNS
Holding in Company
  2:14 pm
RNS
Collaboration Agreement Signed - Replacement
  11:08 am
RNS
Collaboration Agreement Signed with IDM
17 Jan 2000 7:01 am
RNS
Issue of Shares
07 Jan 2000 7:01 am
RNS
New Development in Cancer Therapy
21 Dec 1999 2:02 pm
RNS
Acquisition of Novel Antibody Technology Complete
22 Nov 1999 4:11 pm
RNS
Holding in Company
16 Nov 1999 7:14 am
RNS
Preclinical Results - Parkinson's Disease Product
17 Aug 1999 7:30 am
RNS
Interim Results
26 Jul 1999 9:17 am
RNS
Directorate

a d v e r t i s e m e n t